Physicians should not be falsely reassured by claims that a new treatment appears to have passed a narrowly-defined regulatory test. The management of diabetic patients often carries with it the risk of important cardiovascular consequences, even for drugs that do not overtly increase the risk of myocardial infarction or stroke (Diabetes, Obesity and Metabolism)
Diabetes News
Tag: antihyperglycemic
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review
There is limited evidence available regarding deprescribing antihyperglycemic medications. Adequately powered, high-quality studies, particularly in the elderly and with clinically important outcomes, are required to support evidence-based decision-making (Diabetes Therapy)
Glycosmedia is also available as an App: